Search

Author/Creator Underhill, C.

1. 32LBA The AGITG ICECREAM Study: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation – analysis of outcomes in patients with refractory metastatic colorectal cancer harbouring the KRAS G13D mutation. (September 2015)

Authors:
Segelov, E.; Thavaneswaran, S.; Waring, P.; Desai, J.; Mann, K.; Elez, E.; Chantrill, L.; Pavlakis, N.; Nott, L.; Underhill, C.; Khasraw, M.; Wasan, H.; Ciardiello, F.; Jefford, M.; Joubert, W.; Haydon, A.; Karapetis, C.; Price, T.; Wilson, K.; Shapiro, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S726
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Guidelines for timely initiation of chemotherapy: a proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy services. Issue 8 (August 2016)

Authors:
Alexander, M.; Beattie‐Manning, R.; Blum, R.; Byrne, J.; Hornby, C.; Kearny, C.; Love, N.; McGlashan, J.; McKiernan, S.; Milar, J. L.; Murray, D.; Opat, S.; Parente, P.; Thomas, J.; Tweddle, N.; Underhill, C.; Whitfield, K.; Kirsa, S.; Rischin, D.
Journal:
Internal medicine journal
Issue:
Volume 46:Issue 8(2016)
Page Start:
964
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial. Issue 213 (May 2022)

Authors:
Alexander, M.; Harris, S.J.; Underhill, C.; Torres, J.; Sharma, S.; Lee, N.; Wong, H.; Eek, R.; Michael, M.; Tie, J.; Rogers, J.; Heriot, A.; Ball, D.; MacManus, M.; Wolfe, R.; Solomon, B.; Burbury, K.
Journal:
Thrombosis research
Issue:
Issue 213(2022)Supplement 2
Page Start:
S9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score. Issue 213 (May 2022)

Authors:
Alexander, M.; Harris, S.J.; Underhill, C.; Torres, J.; Sharma, S.; Lee, N.; Wong, H.; Eek, R.; Michael, M.; Tie, J.; Rogers, J.; Heriot, A.; Ball, D.; MacManus, M.; Wolfe, R.; Solomon, B.; Burbury, K.
Journal:
Thrombosis research
Issue:
Issue 213(2022)Supplement 2
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study. Issue 8 (August 2014)

Authors:
O'Carrigan, B.; Fournier, M.; Olver, I. N.; Stockler, M. R.; Whitford, H.; Toner, G. C.; Thomson, D. B.; Davis, I. D.; Hanning, F.; Singhal, N.; Underhill, C.; Clingan, P.; McDonald, A.; Boland, A.; Grimison, P.; Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Journal:
Internal medicine journal
Issue:
Volume 44:Issue 8(2014)
Page Start:
813
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗